Ligand validation:6L38

GW9: 2-chloro-5-nitro-N-phenylbenzamide

GW9 is a Ligand Of Interest in 6L38 designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6L38_GW9_A_502	18%	40%	0.249	0.835	1.35	1.03	4	3	3	0	100%	0.9474
6L38_GW9_B_501	13%	48%	0.32	0.863	1.42	0.62	4	-	0	0	100%	0.9474
6L38_GW9_A_501	11%	45%	0.331	0.856	1.43	0.74	4	-	0	0	100%	0.9474
6L38_GW9_B_502	6%	43%	0.311	0.744	1.43	0.81	4	1	1	0	100%	0.9474
6KYP_GW9_A_501	44%	46%	0.214	0.944	1.42	0.71	4	-	2	0	100%	0.9474
6L37_GW9_B_502	33%	45%	0.25	0.928	1.44	0.72	4	-	1	0	100%	0.9474
6L36_GW9_A_503	24%	39%	0.292	0.921	1.41	1.04	4	2	2	0	100%	0.9474
8FHE_GW9_B_501	82%	45%	0.096	0.95	1.36	0.8	3	-	1	0	100%	0.9474
3B0R_GW9_B_1	56%	55%	0.124	0.897	0.62	1.11	-	2	0	0	100%	0.9474
6AVI_GW9_B_501	41%	40%	0.181	0.897	1.26	1.13	2	1	1	0	100%	0.9474

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.